[1]王家玉肖磊胡亚澜陈琳.带量采购药品配送企业评价体系构建与应用[J].中国卫生质量管理,2023,30(07):074-77.[doi:10.13912/j.cnki.chqm.2023.30.7.16 ]
　WANG Jiayu,XIAO Lei,HU Yalan.Establishment and Practice of Evaluation System of Drug Distribution Enterprises with Quantity Purchase[J].Chinese Health Quality Management,2023,30(07):074-77.[doi:10.13912/j.cnki.chqm.2023.30.7.16 ]
点击复制

带量采购药品配送企业评价体系构建与应用
分享到：

《中国卫生质量管理》[ISSN:1006-7515/CN:CN 61-1283/R]

卷:
第30卷
期数:
2023年07期
页码:
074-77
栏目:
药品质量
出版日期:
2023-07-15

文章信息/Info

Title:
Establishment and Practice of Evaluation System of Drug Distribution Enterprises with Quantity Purchase
作者:
王家玉肖磊胡亚澜陈琳
重庆市妇幼保健院/重庆医科大学附属妇女儿童医院
Author(s):
WANG Jiayu; XIAO Lei; HU Yalan
Chongqing Health Center for Women and Children/Women and Children's Hospital of Chongqing Medical University
关键词:
医疗机构; 集中带量采购; 配送企业; 评价体系; 药品供应行为
Keywords:
Medical Institutes;  Quantity Purchase;  Distribution Enterprises;  Evaluation System;  Drug Supply Process
分类号:
R197.323
DOI:
10.13912/j.cnki.chqm.2023.30.7.16
文献标志码:
A
摘要:
目的构建带量采购药品配送企业评价体系，提升配送服务质量。方法通过文献研究拟订初始指标，经三轮专家咨询构建包含首营资料、配送情况、入库验收、解决问题效率、紧急事件处理、发票配合共6个一级指标20个二级指标的带量采购药品配送企业评价体系。对参与带量采购的10家配送企业2021年度的配送行为进行评价。结果10家配送企业2021年上半年平均扣分为（10.1±5.2）分。公布评价办法、上半年得分以及实施干预措施后，10家配送企业2021年下半年平均扣分减少至（5.8±3.2）分，配送服务质量显著提升（P＜0.05）。结论带量采购药品配送企业评价体系有利于提高配送企业服务质量。还需在保证药品质量、药品供应以及医疗机构带量采购指标完成等方面持续改进。
Abstract:
ObjectiveTo develop an evaluation system of drug delivery enterprises with quantity purchase to improve the quality of delivery service.MethodsThe initial indicators were formulated through literature research, and the evaluation system of drug delivery enterprises with quantity purchase was constructed through three rounds of expert consultation, including the first marketing data, distribution situation, warehousing acceptance, problem solving efficiency, emergency handling, invoice coordination of 6 items and 20 indicators. The 2021 delivery behavior of 10 distribution enterprises participating in the volume purchase was evaluated.ResultsThe average deduction for the 10 distribution companies in the first half of 2021 was （10.1±5.2） points. After the publication of evaluation methods, scores in the first half of the year and the implementation of intervention measures, the average score deduction of 10 distribution enterprises in the second half of the year was reduced to (5.8±3.2) points, and the quality of delivery service was significantly improved (P<0.05). Conclusion The evaluation system of drug distribution enterprises is beneficial to improve the service quality of drug distribution enterprises. Continuous improvement is also needed to ensure drug quality, drug supply and the completion of procurement targets for medical institutions.

参考文献/References:

［1］陈珉惺，徐 源，何江江，等.国家药品集中采购中标企业规模结构分析及启示［J］.中国卫生经济，2022，41（4）：67-69. ［2］王永杰，许 红，俞亚静，等.药品集中带量采购背景下芜湖市第一人民医院ARB类降压药使用情况分析［J］.中国药事，2022，36（3）：355-362. ［3］梁 刚，赵福兰，周彦池，等.药品集中带量采购政策的执行问题及对策建议［J］.中国药物经济学，2022，17（3）：5-8. ［4］郭振军，左 燕，廉江平,等.以重点监控药品管理促进合理用药水平提升［J］.中国卫生质量管理，2022，29（9）：68-71. ［5］张 颖,季聪华,李秋爽,等.中医临床实践指南制修订中德尔菲法的统计分析方法［J］.中华中医药杂志,2018,33(1):249-251. ［6］杨 静,党 勇,张丽芳.我国社区卫生服务机构绩效评估指标体系［J］.中国卫生经济,2010,29(4):52-54. ［7］MUNDY L, MERLIN TL, PARRELLA A, et al. The Australia and New Zealand horizon scanning network［J］. Aust Health Rev, 2005, 29(4): 395-397. ［8］罗雪燕,罗明静.重庆市带量采购前后高血压类药品使用情况分析［J］.重庆第二师范学院学报,2022,35(3):30-34. ［9］何 明,林莲朱,郭 芳,等.某院药品带量采购状况及问题分析［J］.临床合理用药杂志,2022,15(33):178-181. ［10］张秋玉，王 芸，胡元霞，等.我国药品及医用耗材集中带量采购政策的实施现状及建议［J］.中国药房，2022，33（2）：136-141. ［11］袁志远，高 杰，杨才君.多种药品集中配送路径优化研究［J］.工业工程与管理，2020，27（1）：21-29. ［12］张 楠,杨慧鹃,王 鑫,等.供应-调剂-配送供应链系统用于医院药品管理效果评价［J］.中国药业,2021,30(4):21-24. ［13］申帅帅,刘 军.药品供给-加工-配送供应链管理效果评价指标体系的构建与实证［J］.医药导报,2019,38(11):1519-1523. ［14］陈 喆,沈 赟,秦 艳,等.互联网医院安全合理用药闭环管理体系的建立与实践效果评价［J］.中国临床药学杂志,2022,31(1):15-20. ［15］刘晨辰，杨 娟，汪春红,等.RBRVS-KPI模式下公立医院绩效考核体系构建及应用［J］.中国卫生质量管理，2021，28（5）：44-47. ［16］康庆伟，阎 姝.药品供应链延伸模式探讨［J］.中国卫生质量管理，2020，27（2）：104-105，130.

相似文献/References:

[1]袁玉荣,潘修银.2014年宜昌市医疗机构输血情况调查与分析[J].中国卫生质量管理,2015,22(06):104.
[2]杨玉丽 魏海英 王涛 袁萍 马丽.日本医疗机构评审概述及启示[J].中国卫生质量管理,2018,25(05):131.[doi:10.13912/j.cnki.chqm.2018.25.5.38]
[3]龚芳 孙湛.加强医疗技术临床应用事中事后监管的探析[J].中国卫生质量管理,2019,26(01):025.[doi:10.13912/j.cnki.chqm.2019.26.1.09]
[4]归纯漪 孙梅.上海市某三甲专科医院医疗风险相关事件调查分析[J].中国卫生质量管理,2019,26(02):053.[doi:10.13912/j.cnki.chqm.2019.26.2.17]
[5]齐玉梅马旭东刘先夺马方秦环龙马向华胡雯李增宁.全国医疗机构临床营养医疗服务与质量安全调研[J].中国卫生质量管理,2021,28(11):034.[doi:10.13912/j.cnki.chqm.2021.28.11.08 ]
　QI Yumei,MA Xudong,LIU Xianduo.Investigation and Analysis of Clinical Nutrition Medical Service and Quality Safety in Medical Institutions in China[J].Chinese Health Quality Management,2021,28(07):034.[doi:10.13912/j.cnki.chqm.2021.28.11.08 ]
[6]陈练石慧峰魏瑗王晓霞赵扬玉乔杰.2019年度全国产科专业医疗服务与质量安全报告分析[J].中国卫生质量管理,2022,29(05):001.[doi:10.13912/j.cnki.chqm.2022.29.5.01 ]
　CHEN Lian,SHI Huifeng,WEI Yuan.Analysis of the Report on Medical Service and Quality Safety of Obstetrics in China in 2019[J].Chinese Health Quality Management,2022,29(07):001.[doi:10.13912/j.cnki.chqm.2022.29.5.01 ]
[7]王巍马丽平李莹郭云剑.苏、沪、粤三省市医疗服务标准实施现状调查[J].中国卫生质量管理,2022,29(05):053.[doi:10.13912/j.cnki.chqm.2022.29.5.14 ]
　WANG Wei,MA Liping,LI Ying.Investigation of the Implementation Status of Medical Service Standards in Jiangsu, Shanghai and Guangdong Provinces[J].Chinese Health Quality Management,2022,29(07):053.[doi:10.13912/j.cnki.chqm.2022.29.5.14 ]
[8]舒 婷徐 帆 李红霞张 蕾.我国医联体内医疗机构信息化建设现状调研[J].中国卫生质量管理,2022,29(12):001.[doi:10.13912/j.cnki.chqm.2022.29.12.01 ]
　SHU Ting,XU Fan,LI Hongxia.A Cross-Sectional Investigation on Informatization Construction of Medical Institutions in the Medical Alliance in China[J].Chinese Health Quality Management,2022,29(07):001.[doi:10.13912/j.cnki.chqm.2022.29.12.01 ]
[9]王平.《医疗机构门诊质量管理暂行规定》意义解读[J].中国卫生质量管理,2023,30(02):020.[doi:10.13912/j.cnki.chqm.2023.30.2.06 ]
　WANG Ping.Interpretation of "Interim Provisions on Quality Management of Outpatient Service in Medical Institutions"[J].Chinese Health Quality Management,2023,30(07):020.[doi:10.13912/j.cnki.chqm.2023.30.2.06 ]
[10]崔有文董静怡姚京京冯熙龙.医疗机构重点人群核酸检测监管平台构建与应用[J].中国卫生质量管理,2023,30(03):068.[doi:10.13912/j.cnki.chqm.2023.30.3.14 ]
　CUI Youwen,DONG Jingyi,YAO Jingjing.Construction and Application of Nucleic Acid Detection Monitoring Platform for Key Population in Medical Institutions[J].Chinese Health Quality Management,2023,30(07):068.[doi:10.13912/j.cnki.chqm.2023.30.3.14 ]

更新日期/Last Update: 2023-07-15